Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5244]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Benefits and drawbacks of dexrazoxane
Dr Robin Jones - The Institute of Cancer Research, London, UK
Benefits and drawbacks of dexrazoxane ( Dr Robin Jones - The Institute of Cancer Research, London, UK )
15 Nov 2017
Adoptive cell therapy for solid tumours
Dr Sophie Papa - Guy's Hospital, London, UK
Adoptive cell therapy for solid tumours ( Dr Sophie Papa - Guy's Hospital, London, UK )
18 Oct 2017
Checkpoint inhibition in practice and in public
Dr Christy Ralph - St. James's Institute of Oncology, Leeds, UK
Checkpoint inhibition in practice and in public ( Dr Christy Ralph - St. James's Institute of Oncology, Leeds, UK )
18 Oct 2017
The next steps for effective cancer immunotherapy and viral vaccines
Prof Peter Selby - St James University Hospital, Leeds, UK
The next steps for effective cancer immunotherapy and viral vaccines ( Prof Peter Selby - St James University Hospital, Leeds, UK )
18 Oct 2017
Editor's Choice for September 2017
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for September 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
27 Sep 2017
Respiratory microbiomes and lung cancer from mining communities
Prof Luis Mur - Aberystwyth University, Aberystywth, Wales
Respiratory microbiomes and lung cancer from mining communities ( Prof Luis Mur - Aberystwyth University, Aberystywth, Wales )
21 Sep 2017
ESMO 2017 roundup with Dr Bishal Gyawali (1/2)
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (1/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017
ESMO 2017 roundup with Dr Bishal Gyawali (2/2)
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (2/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017
LORELEI trial of letrozole and taselisib for ER positive breast cancer
Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
LORELEI trial of letrozole and taselisib for ER positive breast cancer ( Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
11 Sep 2017
Nivolumab and ipilimumab for metastatic kidney cancer
Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France
Nivolumab and ipilimumab for metastatic kidney cancer ( Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France )
11 Sep 2017
Biological insight in new drug combinations
Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
Biological insight in new drug combinations ( Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
11 Sep 2017
BRIM8: Vemurafenib in high risk melanoma patients
Dr Karl Lewis - University of Colorado Denver, Colorado, USA
BRIM8: Vemurafenib in high risk melanoma patients ( Dr Karl Lewis - University of Colorado Denver, Colorado, USA )
11 Sep 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation